The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Open accessAbstract
The shared role of amyloid-β (Aβ) deposition in cerebral amyloid angiopathy (CAA) and Alzheimer disease (AD) is arguably the clearest instance of crosstalk between neurodegenerative and cerebrovascular processes. The pathogenic pathways of CAA and AD intersect at the levels of Aβ generation, its circulation within the interstitial fluid and perivascular drainage pathways and its brain clearance, but diverge in their mechanisms of brain injury and disease presentation. Here, we review the evidence for and the pathogenic implications of interactions between CAA and AD. Both pathologies seem to be driven by impaired Aβ clearance, creating conditions for a self-reinforcing cycle of increased vascular Aβ, reduced perivascular clearance and further CAA and AD progression. Despite the close relationship between vascular and plaque Aβ deposition, several factors favour one or the other, such as the carboxy-terminal site of the peptide and specific co-deposited proteins. Amyloid-related imaging abnormalities that have been seen in trials of anti-Aβ immunotherapy are another probable intersection between CAA and AD, representing overload of perivascular clearance pathways and the effects of removing Aβ from CAA-positive vessels. The intersections between CAA and AD point to a crucial role for improving vascular function in the treatment of both diseases and indicate the next steps necessary for identifying therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, brains from COVID patients also show ischemic and hemorrhagic lesions, as well as microglial activation [79], which can be seen in many AD patients with cerebral amyloid angiopathy [80].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, vascular deposits of Aβ peptides (amyloid angiopathy) are increasingly recognized as a common pathology in AD cases, supporting that Aβ peptides circulate within the interstitial fluid, including CSF, and blood vessels through perivascular (e.g. lymphatic) drainage pathways during the crosstalk between the brain and the vascular system [77].”
From Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Recently, vascular deposits of Aβ peptides (amyloid angiopathy) are increasingly recognized as a common pathology in AD cases, supporting that Aβ peptides circulate within the interstitial fluid, including CSF, and blood vessels through perivascular (e.g. lymphatic) drainage pathways during the crosstalk between the brain and the vascular system [77].”
From Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Inflammation does, however, not seem to be a major component in CAA-related microhemorrhage or microinfarction [38], with the exception of a rare clinical subtype: CAA-related inflammation [6].”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [6]
In the citing paper
“AQP4 levels are reduced in CAA; since AQP4 plays a vital role in glymphatic Aβ clearance in AD brain parenchyma, this consequently impairs Aβ clearance [606, 608].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [608]
In the citing paper
“AQP4 levels are reduced in CAA; since AQP4 plays a vital role in glymphatic Aβ clearance in AD brain parenchyma, this consequently impairs Aβ clearance [606, 608].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [608]
In the citing paper
“Chronic inflammation‐induced disruption of the BBB is an early biomarker of human cognitive dysfunction and often leads to dementia, 113 and both Aβ deposits and tau pathology aggravate vascular damage. 114 , 115”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [115]
In the citing paper
“There is overwhelming evidence for cerebrovascular alterations in AD pathology and amyloid-β deposition around leptomeningeal vessels is a hall mark of cerebral amyloid angiopathy, occurring in almost all AD patients”
From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Greenberg et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Self-citation
Cited by
Sorted by citations
Items 201–300 of 954
Central Nervous System Pericytes Contribute to Health and Disease
Girolamo, F., Errede, M., Bizzoca, A., Virgintino, D., & Ribatti, D. (2022) · Cells · doi:10.3390/cells11101707 · Cited by 32
Crouch, E. E., Joseph, T., Marsan, E., & Huang, E. J. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.04.007 · Cited by 34
Jiang, Z., Wang, J., Qin, Y., Liu, S., Luo, B., Bai, F., Wei, H., Zhang, S., Wei, J., Ding, G., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01392-0 · Cited by 32
The Impact of Anti-Amyloid Immunotherapies on Stroke Care
Bilodeau, P., Dickson, J. R., & Kozberg, M. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051245 · Cited by 32
Al-Kuraishy, H. M., Sulaiman, G. M., Mohammed, H. A., Dawood, R. A., Albuhadily, A. K., Al-Gareeb, A. I., Abomughaid, M. M., & Klionsky, D. J. (2025) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12525 · Cited by 31
Cheng, X., Su, Y., Wang, Q., Gao, F., Ye, X., Wang, Y., Xia, Y., Fu, J., Shen, Y., Salman, R. A., et al. (2020) · Aging · doi:10.18632/aging.103927 · Cited by 31
New Perspectives of Taxifolin in Neurodegenerative Diseases
Yang, R., Yang, X.-X., & Zhang, F. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230203101107 · Cited by 31
Marazuela, P., Paez-Montserrat, B., Bonaterra-Pastra, A., Solé, M., & Hernández-Guillamon, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094972 · Cited by 31
Off-label use of aducanumab for cerebral amyloid angiopathy
Greenberg, S. M., Cordonnier, C., Schneider, J. A., Smith, E. E., van Buchem, M. A., van Veluw, S. J., Verbeek, M. M., Viswanathan, A., & Werring, D. J. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00213-1 · Cited by 30
Self-citationIcariin: A Potential Neuroprotective Agent in Alzheimer’s Disease and Parkinson’s Disease
Khezri, M. R., & Ghasemnejad‐Berenji, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03667-0 · Cited by 30
de Sousa, A. A., Dames, B. A. R., Graff, E. C., Mohamedelhassan, R., Vassilopoulos, T., & Charvet, C. J. (2023) · Communications Biology · doi:10.1038/s42003-023-05034-3 · Cited by 36
Kelly, L., Brown, C., Michalik, D., Hawkes, C. A., Aldea, R., Agarwal, N., Salib, R. J., Alzetani, A., Ethell, D. W., Counts, S., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13512 · Cited by 31
Wu, C., Lin, T., Ding, Q., Zhang, N., Ou, Z.-T., Cai, G., Chen, H., Xu, J.-Y., Li, G., Pei, Z., et al. (2022) · Mediators of Inflammation · doi:10.1155/2022/2140524 · Cited by 29
Zotin, M. C. Z., Makkinejad, N., Schneider, J. A., Arfanakis, K., Charidimou, A., Greenberg, S. M., & van Veluw, S. J. (2023) · Neurology · doi:10.1212/wnl.0000000000207940 · Cited by 30
Self-citationGreenberg, S. M., & van Veluw, S. J. (2024) · Stroke · doi:10.1161/strokeaha.124.044293 · Cited by 29
Self-citationCharidimou, A., & Smith, E. E. (2024) · Stroke · doi:10.1161/strokeaha.123.044167 · Cited by 32
Leitner, D., Kavanagh, T., Kanshin, E., Balcomb, K., Pires, G., Thierry, M., Suazo, J. I., Schneider, J. A., Ueberheide, B. M., Drummond, E., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02767-1 · Cited by 30
Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's‐related phenotypes
Feng, Y., Wang, S., Yang, D., Wu, Z., Xia, H., Zhu, Q., Wang, Z., Hu, B., Jiang, X., Qin, X., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14543 · Cited by 32
Protein aggregation in neurodegenerative diseases
Wang, J., Dai, L., & Zhang, Z. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003802 · Cited by 29
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Tanaka, M., Saitô, S., Inoue, T., Satoh‐Asahara, N., & Ihara, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061992 · Cited by 31
Trehalose Conjugates of Silybin as Prodrugs for Targeting Toxic Aβ Aggregates
García‐Viñuales, S., Ahmed, R., Sciacca, M. F. M., Lanza, V., Giuffrida, M. L., Zimbone, S., Romanucci, V., Zarrelli, A., Bongiorno, C., Spinella, N., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00232 · Cited by 29
Detection of Cerebral Microbleeds With Venous Connection at 7-Tesla MRI
Rotta, J., Perosa, V., Yakupov, R., Kuijf, H. J., Schreiber, F., Dobisch, L., Oltmer, J., Assmann, A., Speck, O., Heinze, H., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011790 · Cited by 29
He, L., & Sun, Y. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00762-z · Cited by 30
ARCAM-1 Facilitates Fluorescence Detection of Amyloid-Containing Deposits in the Retina
Cao, K., Kim, J. H., Kroeger, H., Gaffney, P. M., Lin, J. H., Sigurdson, C. J., & Yang, J. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.7.5 · Cited by 29
Main features of hereditary cerebral amyloid angiopathies: A systematic review
Biffi, A. (2022) · Cerebral Circulation - Cognition and Behavior · doi:10.1016/j.cccb.2022.100124 · Cited by 30
Grangeon, L., Paquet, C., Guey, S., Zaréa, A., Martinaud, O., Rothärmel, M., Maltête, D., Quillard‐Muraine, M., Nicolas, G., Charbonnier, C., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215208 · Cited by 29
Tachida, Y., Miura, S., Imamaki, R., Ogasawara, N., Takuwa, H., Sahara, N., Shindo, A., Matsuba, Y., Saito, T., Taniguchi, N., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101880 · Cited by 28
Munting, L. P., Bonnar, O., Kozberg, M. G., Auger, C. A., Hirschler, L., Hou, S. S., Greenberg, S. M., Bacskai, B. J., & van Veluw, S. J. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231152550 · Cited by 28
Self-citationSex Differences in Onset and Progression of Cerebral Amyloid Angiopathy
Koemans, E. A., Castello, J. P., Rasing, I., Abramson, J. R., Voigt, S., Perosa, V., van Harten, T. W., van Zwet, E. W., Terwindt, G. M., Gurol, M. E., et al. (2023) · Stroke · doi:10.1161/strokeaha.122.040823 · Cited by 28
Self-citationWang, S., Wang, J., Dove, A. E., Guo, J., Yang, W., Qi, X., Bennett, D. A., & Xu, W. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12910 · Cited by 27
Xu, H., Luo, Z., Zhang, R., Golovynska, I., Huang, Y., Samanta, S., Zhou, T., Li, S., Guo, B., Liu, L., et al. (2023) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2023.112816 · Cited by 27
Abushakra, S. R., Porsteinsson, A. P., Sabbagh, M., Watson, D., Power, A., Liang, E., MacSweeney, E., Boada, M., Flint, S., McLaine, R., et al. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12498 · Cited by 27
Song, R., Han, S., Gao, H., Jiang, H., & Li, X. (2022) · Phytotherapy Research · doi:10.1002/ptr.7384 · Cited by 27
Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology
Gouilly, D., Rafiq, M., Nogueira, L., Salabert, A., Payoux, P., Péran, P., & Pariente, J. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.006 · Cited by 31
Muir, R. T., Ismail, Z., Black, S. E., & Smith, E. E. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13510 · Cited by 27
Jeong, S. Y., Suh, C. H., Kim, S. J., Lemere, C. A., Lim, J.-S., & Lee, J.-H. (2024) · Korean Journal of Radiology · doi:10.3348/kjr.2024.0105 · Cited by 26
Hemostasis components in cerebral amyloid angiopathy and Alzheimer’s disease
Ziliotto, N., Bernardi, F., & Piazza, F. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05327-7 · Cited by 26
Mass Spectrometry Imaging in Alzheimer's Disease
Ikegawa, M., Kakuda, N., Miyasaka, T., Toyama, Y., Nirasawa, T., Minta, K., & Hanrieder, J. (2023) · Brain Connectivity · doi:10.1089/brain.2022.0057 · Cited by 26
Fang, X., Border, J. J., Rivers, P. L., Zhang, H., Williams, J. M., Fan, F., & Roman, R. J. (2023) · GeroScience · doi:10.1007/s11357-023-00841-2 · Cited by 25
Bonkhoff, A. K., Coughlan, G., Perosa, V., Alhadid, K., Schirmer, M. D., Regenhardt, R. W., van Veluw, S. J., Buckley, R. F., Fox, M., & Rost, N. S. (2025) · Science Advances · doi:10.1126/sciadv.adt9243 · Cited by 26
Abushakra, S. R., Power, A., Watson, D., Porsteinsson, A. P., Sabbagh, M., MacSweeney, E., Cohen, S., Boada, M., Doraiswamy, P. M., Liang, E., et al. (2025) · Drugs · doi:10.1007/s40265-025-02250-5 · Cited by 31
Anticoagulants for Treatment of Alzheimer’s Disease
Grossmann, K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200610 · Cited by 27
Effect of β-amyloid on blood-brain barrier properties and function
Petrushanko, I. Y., Mitkevich, V. A., & Makarov, A. А. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01052-x · Cited by 28
Theodorou, A., Tsantzali, I., Stefanou, M., Sacco, S., Katsanos, A. H., Shoamanesh, A., Karapanayiotides, T., Koutroulou, I., Stamati, P., Werring, D. J., et al. (2024) · European Stroke Journal · doi:10.1177/23969873241260538 · Cited by 25
Fibrin-targeting immunotherapy for dementia
Kantor, A. B., Akassoglou, K., & Stavenhagen, J. B. (2023) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2023.105 · Cited by 24
Bobbins, A., Davies, M., Lynn, E., Roy, D., Yeomans, A., & Shakir, S. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70021 · Cited by 24
Fatima, G., Ashiquzzaman, A., Kim, S. S., Kim, Y. R., Kwon, H.-S., & Chung, E. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106877 · Cited by 26
Fulcher, J. M., Ives, A. N., Tasaki, S., Kelly, S. S., Williams, S., Fillmore, T., Zhou, M., Moore, R., Qian, W., Paša‐Tolić, L., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100983 · Cited by 25
MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy
Marazuela, P., Solé, M., Bonaterra‐Pastra, A., Pizarro, J., Camacho, J., Martínez-Sáez, E. A., Kuiperij, H. B., Verbeek, M. M., de Kort, A. M., Schreuder, F. H. B. M., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01257-9 · Cited by 24
Ashrafizadeh, M., Zarrabi, A., Najafi, M., Samarghandian, S., Mohammadinejad, R., & Ahn, K. S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6732 · Cited by 24
Chapter 1: A Vision for the Next Quarter Century.
Slavin, R. E. (1991) · Phi Delta Kappan · Cited by 24
Newton, P., the BIOCARD Research Team, Tchounguen, J., Pettigrew, C., Lim, C., Lin, Z., Lu, H., Moghekar, A., Albert, M., & Soldan, A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220846 · Cited by 23
Gibson, A. W., Elser, H. C., Rosso, M., Cornblath, E. J., Fonkeu, Y., Prasad, S., Rothstein, A., Nasrallah, I. M., Wolk, D. A., & Guo, M. H. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14223 · Cited by 23
Kozberg, M. G., Munting, L. P., Hanlin, L. H., Auger, C. A., van den Berg, M. L., Denis de Senneville, B., Hirschler, L., Warnking, J. M., Barbier, E. L., Farrar, C. T., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf186 · Cited by 23
Self-citationAmyloid-Beta Pathology and Cognitive Performance in Centenarians
Rohde, S. K., Luimes, M. C., Lorenz, L. M. C., Fierro‐Hernández, P., Rozemüller, A. J. M., Hulsman, M., Zhang, M., Graat, M., van der Hoorn, M. E., Daatselaar, D., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.1734 · Cited by 26
Human cerebral vascular amyloid contains both antiparallel and parallel in-register Aβ40 fibrils
Irizarry, B. A., Davis, J., Zhu, X. A., Boon, B. D. C., Rozemüller, A. J. M., Nostrand, W. E. V., & Smith, S. O. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101259 · Cited by 23
Grangeon, L., Quesney, G., Verdalle-Cazes, M., Coulette, S., Renard, D., Wacongne, A., Allou, T., Olivier, N., Boukriche, Y., Blanchet-Fourcade, G., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11145-4 · Cited by 23
Grossmann, K. (2022) · Biomedicines · doi:10.3390/biomedicines10081890 · Cited by 24
Glymphatic pathway in sporadic cerebral small vessel diseases: From bench to bedside
Xu, J., Su, Y., Fu, J., Shen, Y., Dong, Q., & Cheng, X. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101885 · Cited by 24
Bernal, J., Schreiber, S., Menze, I., Ostendorf, A., Pfister, M., Geisendörfer, J., Nemali, A., Maaß, A., Yakupov, R., Peters, O., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01243-4 · Cited by 23
Briard, J. N., Duquette, A., Cayrol, R., & Lapalme‐Remis, S. (2024) · Neurology · doi:10.1212/wnl.0000000000209582 · Cited by 23
Plasma β-Amyloid, Total-Tau, and Neurofilament Light Chain Levels and the Risk of Stroke
Heshmatollah, A., Fani, L., Koudstaal, P. J., Ghanbari, M., Ikram, M. A., & Ikram, M. K. (2022) · Neurology · doi:10.1212/wnl.0000000000200004 · Cited by 23
Shively, C. A., Agnès Lacreuse, A., Frye, B. M., Rothwell, E. S., & Moro, M. (2021) · American Journal of Primatology · doi:10.1002/ajp.23309 · Cited by 24
Jackson, J. W., Foster, J. S., Martin, E. B., Macy, S. D., Wooliver, C., Balachandran, M., Richey, T., Heidel, R. E., Williams, A. D., Kennel, S. J., et al. (2022) · Amyloid · doi:10.1080/13506129.2022.2155133 · Cited by 22
Wang, X., Xie, Y., Fan, X., Wu, X., Wang, D., & Li, Z. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01489-6 · Cited by 26
Andrade-Guerrero, J., Orta‐Salazar, E., Salinas‐Lara, C., Sánchez-Garibay, C., Rodríguez-Hernández, L. D., Vargas-Rodríguez, I., Barron-Leon, N., Ledesma-Alonso, C., Díaz-Cintra, S. Y., & Soto-Rojas, L. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311134 · Cited by 23
Tolar, M., Hey, J. A., Power, A., & Abushakra, S. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052727 · Cited by 23
Szidonya, L., & Nickerson, J. P. (2023) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2023.01.009 · Cited by 21
Kobayashi, G., Hirata, K., Ono, M., Kasuga, K., & Takado, Y. (2026) · Frontiers in Dementia · doi:10.3389/frdem.2026.1736297 · Cited by 22
Effects of cerebral amyloid angiopathy on the brain vasculome
Deng, W., Guo, S., van Veluw, S. J., Yu, Z., Chan, S. J., Takase, H., Arai, K., Ning, M., Greenberg, S. M., Lo, E. H., et al. (2022) · Aging Cell · doi:10.1111/acel.13503 · Cited by 21
Self-citationVillain, N., Planche, V., & Lévy, R. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.08.002 · Cited by 24
Badimon, A., Torrente, D., & Norris, E. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087046 · Cited by 21
Amyloid-β: A potential mediator of aging-related vascular pathologies
Khan, F., & Qiu, H. (2023) · Vascular Pharmacology · doi:10.1016/j.vph.2023.107213 · Cited by 22
Zhang, H., Chen, Y., Yu, M., Xi, Y., Han, G., Jin, Y., Wang, G.-J., Sun, X., Zhou, J., & Ding, Y. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304213120 · Cited by 21
Rasing, I., Voigt, S., Koemans, E. A., de Kort, A. M., van Harten, T. W., van Etten, E. S., van Zwet, E. W., Stoops, E., François, C., Kuiperij, H. B., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01457-0 · Cited by 21
Cooperation between neurovascular dysfunction and Aβ in Alzheimer’s disease
Wang, N., Yang, X., Zhao, Z., Liu, D., Wang, X., Tang, H., Zhong, C., Chen, X., Chen, W. K., & Meng, Q. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1227493 · Cited by 22
Tension at the gate: sensing mechanical forces at the blood–brain barrier in health and disease
Hansen, C. E., Hollaus, D., Kamermans, A., & de Vries, H. E. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03321-2 · Cited by 21
Scherlek, A. A., Kozberg, M. G., Nicoll, J. A. R., Perosa, V., Freeze, W. M., van der Weerd, L., Bacskai, B. J., Greenberg, S. M., Frosch, M. P., Boche, D., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac021 · Cited by 20
Self-citationFu, Z., Crooks, E. J., Irizarry, B. A., Zhu, X. A., Chowdhury, S., Nostrand, W. E. V., & Smith, S. O. (2024) · Journal of Structural Biology · doi:10.1016/j.jsb.2024.108092 · Cited by 20
Perosa, V., Arts, T., Assmann, A., Mattern, H., Speck, O., Oltmer, J., Heinze, H.-J., Düzel, E., Schreiber, S., & Zwanenburg, J. J. M. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7450 · Cited by 19
The elusive brain perivascular fibroblast: a potential role in vascular stability and homeostasis
Sosa, M. J., Shih, A. Y., & Bonney, S. K. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1283434 · Cited by 19
Interactions between Beta-Amyloid and Pericytes in Alzheimer’s Disease
Li, Y.-Y., Guo, D.-D., Duan, R., & Li, Y. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904136 · Cited by 19
Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy
Wang, S., Gu, S., Chen, J., Yuan, Z., Liang, P., & Cui, H. (2024) · Biomolecules · doi:10.3390/biom14040480 · Cited by 21
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 19
Endocytosis Is a Key Mode of Interaction between Extracellular β-Amyloid and the Cell Membrane
Shi, J., Zhu, L., Lan, X., Zhao, D.-W., He, Y., Sun, Z.-Q., Wu, D., & Li, H. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.07.035 · Cited by 19
Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
Grossmann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094805 · Cited by 20
Tsay, H.-J., Liu, H., Kuo, Y., Chiu, C.-S., Liang, C.-C., Chung, C.-W., Chen, C., Chen, Y.-P., & Shiao, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910413 · Cited by 19
Xu, C., Garcia, D., Lu, Y., Ozuna, K., Adjeroh, D. A., Wang, K., & Initiative, O. B. O. T. A. D. N. (2021) · Cells · doi:10.3390/cells11010029 · Cited by 19
Rajpoot, J., Crooks, E. J., Irizarry, B. A., Amundson, A., Nostrand, W. E. V., & Smith, S. O. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00781 · Cited by 20
Vargas-Soria, M., Ramos‐Rodríguez, J. J., del Marco, À., Hierro‐Bujalance, C., Carranza-Naval, M. J., Calvo-Rodríguez, M., van Veluw, S. J., Stitt, A. W., Simó, R., Bacskai, B. J., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00380-6 · Cited by 20
Self-citationChen, J., Pan, Y., Liu, Q., Li, G., Chen, G., Li, W., Zhao, W., & Wang, Q. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221115150253 · Cited by 19
Tarafdar, A., Wolska, N., Krisp, C., Schlüter, H., & Pula, G. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102287 · Cited by 18
Phenotype and imaging features associated with APP duplications
Grangeon, L., Charbonnier, C., Zaréa, A., Rousseau, S., Rovelet‐Lecrux, A., Bendetowicz, D., Lemaitre, M., Malrain, C., Quillard‐Muraine, M., Cassinari, K., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01172-2 · Cited by 18
Association between Life’s Essential 8 and cognitive function: insights from NHANES 2011–2014
Liang, K., & Zhang, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1386498 · Cited by 19
Bonaterra‐Pastra, A., de Retana, S. F., Rivas-Urbina, A., Puig, N., Benı́tez, S., Pancorbo, O., Rodríguez‐Luna, D., Pujadas, F., Freijo, M. D. M., Tur, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9010072 · Cited by 21
Yoshiki, K., Hirose, G., Kumahashi, K., Kohda, Y., Ido, K., Shioya, A., Misaki, K., & Kasuga, K. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-021-04751-0 · Cited by 18
Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy
Shirzadi, Z., Yau, W. W., Schultz, S. A., Schultz, A. P., Scott, M. R., Goubran, M., Forooshani, P. M., Joseph‐Mathurin, N., Kantarci, K., Preboske, G. M., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26429 · Cited by 18
Self-citationCaro, I., Western, D., Namba, S., Sun, N., Kawaguchi, S., He, Y., Fujita, M., Roshchupkin, G. V., D’Aoust, T., Duperron, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01006-w · Cited by 22
Ruan, C., Kong, J., He, X., Hu, B., & Zeng, X. (2022) · Food Materials Research · doi:10.48130/fmr-2022-0002 · Cited by 17
Crouzet, C., Phan, T. P., Wilson, R. H., Shin, T. J., & Choi, B. (2023) · Neurophotonics · doi:10.1117/1.nph.10.2.020601 · Cited by 18
Metadata
- Authors
- Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Greenberg, Steven M.
- Venue
- Nature Reviews Neurology
- Published
- 2019-12-11
- Volume
- 16
- Issue
- 1
- Pages
- 30-42
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC7268202
- OpenAlex
- W2995183059
- Cited by
- 947
- References
- 232
- Citations by year
- 2026: 146 · 2025: 198 · 2024: 179 · 2023: 154 · 2022: 113 · 2021: 104 · 2020: 52
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG026484)
- National Institute of Neurological Disorders and Stroke (RF1NS110054, R01NS096730, U24NS100591)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- cerebral amyloid angiopathy, Alzheimer's disease, amyloid-beta, amyloid-beta clearance, amyloid-related imaging abnormalities, anti-amyloid immunotherapy, vascular function
- MeSH terms
- Alzheimer Disease, Brain, Humans, Signal Transduction, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
